01 March 2021
|
min read
In this feature by The Telegraph, Professor Peter Donnelly speaks with journalist Hannah Boland about Genomics plc’s recent oversubscribed funding round. The article highlights how the company is using DNA technology to map health risks and support the shift toward preventative healthcare.
This article was originally published in The Telegraph on 1 March 2021.
